TECHNETIUM Tc 99m MERTIATIDE
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- TECHNETIUM Tc 99m MERTIATIDE
- Generic name
- TECHNETIUM TC 99M MERTIATIDE
- Manufacturer
- Jubilant DraxImage Inc., dba Jubilant Radiopharma
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- d497f2a2-8e8d-4372-ba09-f8e6b22d2cf8
- SPL ID
- c7627788-6211-4255-82a9-ec12343149f8
- Version
- 4
- Effective date
- 2023-01-22
- Source export date
- 2026-11-13
- Source partition
- 12
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-13/df974ce21ba33b4471866e2af5412327fbd4bcd68d14b42d7cfb3aa15d163738/drug-label-0012-of-0014.json.zip
- Source manifest SHA-256
- 8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
- Import run
- 20261116T150851Z
- Imported at
- 2026-11-16 17:44:51
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 216820 | derived:openfda.application_number |
| application number | NDA216820 | openfda.application_number | |
| brand name | TECHNETIUM Tc 99m MERTIATIDE | openfda.brand_name | |
| generic name | TECHNETIUM TC 99M MERTIATIDE | openfda.generic_name | |
| manufacturer name | Jubilant DraxImage Inc., dba Jubilant Radiopharma | openfda.manufacturer_name | |
| ndc | package | 65174-261-01 | openfda.package_ndc |
| ndc | package | 65174-261-05 | openfda.package_ndc |
| ndc | product | 65174-261 | openfda.product_ndc |
| ndc11 | package | 65174026105 | derived:openfda.package_ndc |
| ndc11 | package | 65174026101 | derived:openfda.package_ndc |
| spl id | c7627788-6211-4255-82a9-ec12343149f8 | id | |
| spl set id | d497f2a2-8e8d-4372-ba09-f8e6b22d2cf8 | set_id | |
| unii | 9NV2SR34P8 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
5 WARNINGS AND PRECAUTIONS Radiation risks: Ensure safe handling to minimize radiation exposure to patients and healthcare providers. ( 5.1 ) 5.1 Radiation Risks Technetium Tc 99m Mertiatide Injection contributes to a patient’s overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk for cancer. Ensure safe handling to minimize radiation exposure to the patient and healthcare providers. Advise patients to hydrate before and after administration and to void frequently after administration [ see Dosage and Administration ( 2.2 ) ] .
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
6 ADVERSE REACTIONS The following adverse reactions associated with the use of Technetium Tc 99m Mertiatide Injection were identified in clinical studies or postmarketing reports. Because some of these reactions are voluntarily reported from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Cardiac disorders : tachycardia. Gastrointestinal disorders : nausea, vomiting. General disorders and administration site conditions : shaking chills, fever. Nervous system disorders : seizure. Respiratory, thoracic and mediastinal disorders : wheezing, dyspnea. Skin and subcutaneous tissue disorders : itching, rash. Vascular disorders : elevation in blood pressure. Reported adverse reactions are: tachycardia, nausea, vomiting, shaking chills, fever, seizure, wheezing, dyspnea, itching, rash, and elevation in blood pressure. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Jubilant DraxImage Inc. at 1-888-633-5343 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.